|
|
|
Breast Cancer Patients with the Breast Cancer Susceptibility Gene Are Poor Candidates for Some Chemotherapy Drugs
Researchers at Jefferson Medical College have found that alterations in a breast cancer susceptibility gene can change the effectiveness of certain chemotherapy drugs against the disease. The work highlights the new field of pharmacogenomic therapy, which has become increasingly important with the sequencing of the human genome and, it is hoped, will lead to improved cancer therapies.
Published: 3-27-2001
Media Only Contact: Steven Benowitz Thomas Jefferson University Hospital
Phone: 215/955-6300
Message posted by: Wouter Kalle
|
|
Variants Associated with Pediatric Allergic Disorder
Mutations in PHF6 Found in T-Cell Leukemia
Genetic Risk Variant for Urinary Bladder Cancer
Antibody Has Therapeutic Effect on Mice with ALS
Regulating P53 Activity in Cancer Cells
Anti-RNA Therapy Counters Breast Cancer Spread
Mitochondrial DNA Diversity
The Power of RNA Sequencing
‘Pro-Ageing' Therapy for Cancer?
Niche Genetics Influence Leukaemia
Molecular Biology: Clinical Promise for RNA Interference
Chemoprevention Cocktail for Colon Cancer
more news ...
|